A. Wardle, R. Wardle, K. Luyt, and R. Tulloh, The utility of sildenafil in pulmonary hypertension: a focus on bronchopulmonary dysplasia, Archives of Disease in Childhood, vol.8, issue.Suppl 1, pp.613-620, 2013.
DOI : 10.1136/archdischild-2012-303333

D. Cerro, M. , S. Rotés, A. Cartón, A. Deiros et al., Pulmonary hypertension in bronchopulmonary dysplasia: Clinical findings, cardiovascular anomalies and outcomes, Pediatric Pulmonology, vol.306, issue.1, pp.49-59, 2014.
DOI : 10.1002/ppul.22797

N. Galiè, M. Hoeper, and M. Humbert, Task Force for Diagnosis and Treatment of Pulmonary Hypertension of European Society of Cardiology (ESC) Guidelines for the diagnosis and treatment of pulmonary hypertension, International Society of Heart and Lung Transplantation (ISHLT), pp.1219-63, 2009.

P. Mourani, M. Mullen, and S. Abman, Pulmonary hypertension in bronchopulmonary dysplasia, Progress in Pediatric Cardiology, vol.27, issue.1-2
DOI : 10.1016/j.ppedcard.2009.09.007

R. Wang, F. Jiang, Q. Zheng, C. Li, X. Peng et al., Efficacy and safety of sildenafil treatment in pulmonary arterial hypertension: A systematic review, Respiratory Medicine, vol.108, issue.3, 2014.
DOI : 10.1016/j.rmed.2014.01.003

P. Oishi, S. Datar, and J. Fineman, Advances in the management of pediatric pulmonary hypertension. Respir Care, pp.1314-1353, 2011.

A. Widlitz and R. Barst, Pulmonary arterial hypertension in children, European Respiratory Journal, vol.21, issue.1, 2003.
DOI : 10.1183/09031936.03.00088302

E. Dumas-de-la-roque, L. Storme, P. Mauriat, and S. Bonnet, Pulmonary hypertension in pediatric and neonatal intensive care unit. Part I: Physiopathology. Arch Pediatr, pp.68-75, 2011.

M. Humbert, N. Morrell, S. Archer, K. Stenmark, M. Maclean et al., Cellular and molecular pathobiology of pulmonary arterial hypertension, Journal of the American College of Cardiology, vol.43, issue.12, 2004.
DOI : 10.1016/j.jacc.2004.02.029

L. Storme, R. Rairigh, T. Parker, J. Kinsella, and S. Abman, In Vivo Evidence for a Myogenic Response in the Fetal Pulmonary Circulation, Pediatric Research, vol.268, issue.3, pp.425-456, 1999.
DOI : 10.1203/00006450-199903000-00022

S. Berkelhamer, K. Mestan, and R. Steinhorn, Pulmonary hypertension in bronchopulmonary dysplasia, Seminars in Perinatology, vol.37, issue.2, pp.124-155
DOI : 10.1053/j.semperi.2013.01.009

A. Milan, C. Magnino, and F. Veglio, Echocardiographic Indexes for the Non-Invasive Evaluation of Pulmonary Hemodynamics, Journal of the American Society of Echocardiography, vol.23, issue.3, pp.225-264, 2010.
DOI : 10.1016/j.echo.2010.01.003

J. Collaco, L. Romer, B. Stuart, J. Coulson, A. Everett et al., Frontiers in pulmonary hypertension in infants and children with bronchopulmonary dysplasia, Pediatric Pulmonology, vol.116, issue.11, pp.1042-53, 2012.
DOI : 10.1002/ppul.22609

G. Kim, Pulmonary hypertension in infants with bronchopulmonary dysplasia, Korean Journal of Pediatrics, vol.53, issue.6, pp.688-93, 2010.
DOI : 10.3345/kjp.2010.53.6.688

E. Dumas-de-la-roque, L. Storme, P. Mauriat, and S. Bonnet, Pulmonary hypertension in pediatric and neonatal intensive care unit. Part II: diagnosis and treatment. Arch Pediatr, Feb, vol.18, issue.2, pp.195-203, 2011.

B. Stenson, W. Tarnow-mordi, and B. Darlow, BOOST II United Kingdom Collaborative Group, BOOST II Australia Collaborative Group, BOOST II New Zealand Collaborative Group, Oxygen saturation and outcomes in preterm infants, N Engl J Med, vol.368, issue.22, pp.2094-104, 2013.

V. Meau-petit, G. Thouvenin, N. Guillemot-lambert, V. Champion, I. Tillous-borde et al., Bronchopulmonary dysplasia-associated pulmonary arterial hypertension of very preterm infants. Arch Pediatr, pp.44-53, 2013.

M. Humbert, O. Sitbon, and G. Simonneau, Treatment of Pulmonary Arterial Hypertension, New England Journal of Medicine, vol.351, issue.14, pp.1425-1461, 2004.
DOI : 10.1056/NEJMra040291

URL : https://hal.archives-ouvertes.fr/hal-01455600

J. Pepke-zaba, T. Higenbottam, A. Dinh-xuan, D. Stone, and J. Wallwork, Inhaled Nitric Oxide as a Cause of Selective Pulmonary Vasodilatation in Pulmonary Hypertension, Survey of Anesthesiology, vol.36, issue.6, pp.1173-1177, 1991.
DOI : 10.1097/00132586-199212000-00001

R. Grover, I. Murdoch, M. Smithies, I. Mitchell, and D. Bihari, Nitric oxide during hand ventilation in patient with acute respiratory failure, The Lancet, vol.340, issue.8826, pp.1038-1047, 1992.
DOI : 10.1016/0140-6736(92)93052-O

J. Skimming, K. Bender, A. Hutchison, and W. Drummond, Nitric oxide inhalation in infants with respiratory distress syndrome, The Journal of Pediatrics, vol.130, issue.2, pp.225-255, 1997.
DOI : 10.1016/S0022-3476(97)70347-0

B. Banks, I. Seri, H. Ischiropoulos, J. Merrill, J. Rychik et al., Changes in Oxygenation With Inhaled Nitric Oxide in Severe Bronchopulmonary Dysplasia, PEDIATRICS, vol.103, issue.3, pp.610-618, 1999.
DOI : 10.1542/peds.103.3.610

A. Huddleston, C. Knoderer, J. Morris, and E. Ebenroth, Sildenafil for the Treatment of Pulmonary Hypertension in Pediatric Patients, Pediatric Cardiology, vol.42, issue.851, pp.871-82, 2009.
DOI : 10.1007/s00246-009-9523-1

S. Samiee-zafarghandy, P. Smith, and J. Van-den-anker, Safety of sildenafil in infants. Pediatr Crit Care Med, pp.362-370, 2014.

M. Boolell, M. Allen, S. Ballard, S. Gepi-attee, G. Muirhead et al., Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction, Int J Impot Res, vol.8, issue.2, pp.47-52, 1996.

A. Atz and D. Wessel, Sildenafil Ameliorates Effects of Inhaled Nitric Oxide Withdrawal, Anesthesiology, vol.91, issue.1
DOI : 10.1097/00000542-199907000-00041

D. Abrams, I. Schulze-neick, and A. Magee, Sildenafil as a selective pulmonary vasodilator in childhood primary pulmonary hypertension, Heart, vol.84, issue.2, p.4, 2000.
DOI : 10.1136/heart.84.2.e4

S. Prasad, J. Wilkinson, and M. Gatzoulis, Sildenafil in Primary Pulmonary Hypertension, New England Journal of Medicine, vol.343, issue.18, p.1342, 2000.
DOI : 10.1056/NEJM200011023431814

N. Galiè, H. Ghofrani, A. Torbicki, R. Barst, L. Rubin et al., Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension, New England Journal of Medicine, vol.353, issue.20, pp.2148-57, 2005.
DOI : 10.1056/NEJMoa050010

S. Raja, K. Macarthur, and J. Pollock, Is sildenafil effective for treating pulmonary hypertension after pediatric heart surgery? Interact Cardiovasc Thorac Surg, Feb, vol.5, issue.1, pp.52-56, 2006.

L. Leibovitch, I. Matok, and G. Paret, Therapeutic Applications of Sildenafil Citrate in the Management of Paediatric Pulmonary Hypertension, Drugs, vol.89, issue.1, pp.57-73, 2007.
DOI : 10.2165/00003495-200767010-00005

A. Wardle and R. Tulloh, Paediatric pulmonary hypertension and sildenafil: current practice and controversies. Arch Dis Child Educ Pract Ed, pp.141-148, 2013.

S. Abman, J. Kinsella, E. Rosenzweig, U. Krishnan, T. Kulik et al., Implications of the U.S. Food and Drug Administration Warning against the Use of Sildenafil for the Treatment of Pediatric Pulmonary Hypertension, American Journal of Respiratory and Critical Care Medicine, vol.187, issue.6, pp.572-577, 2013.
DOI : 10.1164/rccm.201210-1928PP

R. Kehat, D. Bonsall, R. North, and B. Connors, Ocular findings of oral sildenafil use in term and near-term neonates, Journal of American Association for Pediatric Ophthalmology and Strabismus, vol.14, issue.2, pp.159-62, 2010.
DOI : 10.1016/j.jaapos.2009.12.161

M. Radicioni, A. Bruni, and P. Camerini, Combination therapy for life-threatening pulmonary hypertension in a premature infant: first report on bosentan use, European Journal of Pediatrics, vol.85, issue.8, 2011.
DOI : 10.1007/s00431-011-1422-9

L. Shekerdemian, H. Ravn, and D. Penny, Intravenous Sildenafil Lowers Pulmonary Vascular Resistance in a Model of Neonatal Pulmonary Hypertension, American Journal of Respiratory and Critical Care Medicine, vol.165, issue.8, pp.1098-102, 2002.
DOI : 10.1164/ajrccm.165.8.2107097

M. Bentlin, A. Saito, D. Luca, A. Bossolan, G. Bonatto et al., Sildenafil for pulmonary hypertension treatment after cardiac surgery, Jornal de Pediatria, vol.81, issue.2, pp.175-183, 2005.
DOI : 10.2223/1325

K. Hon, K. Cheung, K. Siu, T. Leung, M. Yam et al., Oral Sildenafil for Treatment of Severe Pulmonary Hypertension in an Infant, Neonatology, vol.88, issue.2, pp.109-121, 2005.
DOI : 10.1159/000085646

M. Ahsman, B. Witjes, E. Wildschut, I. Sluiter, A. Vulto et al., Sildenafil exposure in neonates with pulmonary hypertension after administration via a nasogastric tube, Archives of Disease in Childhood - Fetal and Neonatal Edition, vol.95, issue.2, pp.109-123, 2010.
DOI : 10.1136/adc.2009.168336

R. Steinhorn, Diagnosis and treatment of pulmonary hypertension in infancy. Early Hum Dev, pp.865-74, 2013.

P. Namachivayam, U. Theilen, W. Butt, S. Cooper, D. Penny et al., Sildenafil Prevents Rebound Pulmonary Hypertension after Withdrawal of Nitric Oxide in Children, American Journal of Respiratory and Critical Care Medicine, vol.174, issue.9, pp.1042-1049, 2006.
DOI : 10.1164/rccm.200605-694OC

K. König, C. Barfield, K. Guy, S. Drew, and C. Andersen, The effect of sildenafil on evolving bronchopulmonary dysplasia in extremely preterm infants: a randomised controlled pilot study, The Journal of Maternal-Fetal & Neonatal Medicine, vol.125, issue.5
DOI : 10.1164/ajrccm.163.7.2011060

J. Stultz, T. Puthoff, C. Backes, and M. Nahata, Intermittent intravenous sildenafil for pulmonary hypertension management in neonates and infants. Am J Health-Syst Pharm AJHP Off J Am Soc Health-Syst Pharm, pp.407-420, 2013.

P. Mourani, M. Sontag, D. Ivy, and S. Abman, Effects of Long-Term Sildenafil Treatment for Pulmonary Hypertension in Infants with Chronic Lung Disease, The Journal of Pediatrics, vol.154, issue.3, pp.379-84, 2009.
DOI : 10.1016/j.jpeds.2008.09.021

A. Hadchouel and C. Delacourt, Dysplasie bronchopulmonaire du nouveau-n?? pr??matur????: d???hier ?? aujourd???hui, Revue de Pneumologie Clinique, vol.69, issue.4, pp.207-223
DOI : 10.1016/j.pneumo.2013.05.003

W. Northway, . Jr, R. Rosan, and D. Porter, Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia, N Engl J Med Feb, vol.16276, issue.7, pp.357-68, 1967.

E. Bancalari and N. Claure, Definitions and Diagnostic Criteria for Bronchopulmonary Dysplasia, Seminars in Perinatology, vol.30, issue.4
DOI : 10.1053/j.semperi.2006.05.002

R. Parad, Update on the diagnosis and management of bronchopulmonary dysplasia/chronic lung disease of infancy: what the radiologist should know, Pediatric Radiology, vol.101, issue.S1, pp.92-100
DOI : 10.1007/s00247-011-2255-4

J. Kinsella, A. Greenough, and S. Abman, Bronchopulmonary dysplasia. Lancet, Apr, vol.29367, issue.9520, pp.1421-1452, 2006.

A. Bhandari and H. Panitch, Pulmonary outcomes in bronchopulmonary dysplasia. Semin Perinatol, pp.219-245, 2006.

J. Coalson, Pathology of new bronchopulmonary dysplasia, Seminars in Neonatology, vol.8, issue.1, 2003.
DOI : 10.1016/S1084-2756(02)00193-8

R. Ehrenkranz, M. Walsh, B. Vohr, A. Jobe, L. Wright et al., Validation of the National Institutes of Health Consensus Definition of Bronchopulmonary Dysplasia, PEDIATRICS, vol.116, issue.6, 2005.
DOI : 10.1542/peds.2005-0249

P. Korhonen, O. Tammela, A. Koivisto, P. Laippala, and S. Ikonen, Frequency and risk factors in bronchopulmonary dysplasia in a cohort of very low birth weight infants, Early Human Development, vol.54, issue.3, 1999.
DOI : 10.1016/S0378-3782(98)00101-7

C. Speer, Pre- and postnatal inflammatory mechanisms in chronic lung disease of preterm infants, Paediatric Respiratory Reviews, vol.5, pp.241-245, 2004.
DOI : 10.1016/S1526-0542(04)90045-0

A. Khan, M. Kuzma-o-'reilly, B. Brodsky, N. Bhandari, and V. , Site-specific characteristics of infants developing bronchopulmonary dysplasia, Journal of Perinatology, vol.26, issue.8, pp.428-463, 2006.
DOI : 10.1038/sj.jp.7211567

W. Oh, B. Poindexter, R. Perritt, J. Lemons, C. Bauer et al., Association between Fluid Intake and Weight Loss during the First Ten Days of Life and Risk of Bronchopulmonary Dysplasia in Extremely Low Birth Weight Infants, The Journal of Pediatrics, vol.147, issue.6, pp.786-90, 2005.
DOI : 10.1016/j.jpeds.2005.06.039

V. Bhandari and J. Gruen, The Genetics of Bronchopulmonary Dysplasia, Seminars in Perinatology, vol.30, issue.4, 2006.
DOI : 10.1053/j.semperi.2006.05.005

M. Rojas, A. Gonzalez, E. Bancalari, N. Claure, C. Poole et al., Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease Respiratory Outcomes of the Surfactant Positive Pressure and Oximetry Randomized Trial (SUPPORT) The chest radiograph appearances of very premature infants at 36 weeks post-conceptional age, J Pediatr. J Pediatr. Br J Radiol, vol.126165, issue.42, pp.605-615, 1995.

S. Aukland, T. Halvorsen, K. Fosse, A. Daltveit, and K. Rosendahl, High-Resolution CT of the Chest in Children and Young Adults Who Were Born Prematurely: Findings in a Population-Based Study, American Journal of Roentgenology, vol.187, issue.4, pp.1012-1020, 2006.
DOI : 10.2214/AJR.05.0383

L. Doyle, W. Kitchen, G. Ford, A. Rickards, J. Lissenden et al., Effects of antenatal steroid therapy on mortality and morbidity in very low birth weight infants, The Journal of Pediatrics, vol.108, issue.2, 1986.
DOI : 10.1016/S0022-3476(86)81006-X

M. Hallman, T. Merritt, A. Jarvenpaa, B. Boynton, F. Mannino et al., Exogenous human surfactant for treatment of severe respiratory distress syndrome: A randomized prospective clinical trial, The Journal of Pediatrics, vol.106, issue.6, pp.963-972, 1985.
DOI : 10.1016/S0022-3476(85)80253-5

D. Roberts and S. Dalziel, Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth):CD004454. 72. Suresh GK, Soll RF. Overview of surfactant replacement trials, Cochrane Database Syst Rev. J Perinatol, vol.25, issue.3 2, pp.40-44, 2005.

M. Rojas-reyes, C. Morley, R. Soll, T. Stevens, E. Harrington et al., Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome, CD003063. 75. Richmond S, Wyllie J. European Resuscitation Council Guidelines for Resuscitation, 2007.

L. Moyer-mileur, D. Nielson, K. Pfeffer, M. Witte, and D. Chapman, Eliminating sleepassociated hypoxemia improves growth in infants with bronchopulmonary dysplasia, Pediatrics, 1996.

J. Kinsella, T. Parker, H. Galan, B. Sheridan, A. Halbower et al., Effects of Inhaled Nitric Oxide on Pulmonary Edema and Lung Neutrophil Accumulation in Severe Experimental Hyaline Membrane Disease, Pediatric Research, vol.37, issue.4, pp.457-63, 1997.
DOI : 10.1203/00006450-199704000-00002

J. Mercier, P. Olivier, G. Loron, R. Fontaine, L. Maury et al., Inhaled nitric oxide to prevent bronchopulmonary dysplasia in preterm neonates, Seminars in Fetal and Neonatal Medicine, vol.14, issue.1, pp.28-34, 2009.
DOI : 10.1016/j.siny.2008.08.009

J. Mercier, H. Hummler, X. Durrmeyer, M. Sanchez-luna, V. Carnielli et al., Inhaled nitric oxide for prevention of bronchopulmonary dysplasia in premature babies (EUNO): a randomised controlled trial, The Lancet, vol.376, issue.9738, pp.346-54, 2010.
DOI : 10.1016/S0140-6736(10)60664-2

B. Stuart, P. Sekar, J. Coulson, S. Choi, S. Mcgrath-morrow et al., Health-care utilization and respiratory morbidities in preterm infants with pulmonary hypertension, Journal of Perinatology, vol.27, issue.7, pp.543-550
DOI : 10.1111/j.1748-720X.2011.00588.x

J. Check, N. Gotteiner, X. Liu, E. Su, N. Porta et al., Fetal growth restriction and pulmonary hypertension in premature infants with bronchopulmonary dysplasia, Journal of Perinatology, vol.33, issue.7, 2013.
DOI : 10.1542/peds.2007-1583

K. Deakins and . Bronchopulmonary-dysplasia, Respir Care, pp.1252-62, 2009.

C. Hsiao, M. Tsai, C. Chen, and H. Lin, Early optimal nutrition improves neurodevelopmental outcomes for very preterm infants, Nutrition Reviews, vol.72, issue.8, pp.532-572, 2014.
DOI : 10.1111/nure.12110

. Audipog, Association des Utilisateurs de Dossiers Informatisés en Pédiatrie, Obstétrique et Gynécologie Available from, 2013.

Z. Ali, P. Schmidt, J. Dodd, D. Jeppesen, H. An et al., Predictors of bronchopulmonary dysplasia and pulmonary hypertension in newborn children Pulmonary hypertension in preterm infants with bronchopulmonary dysplasia, Dan Med J. Korean Circ J, vol.6040, issue.863, pp.4688131-4688137, 2010.

M. Farquhar and D. Fitzgerald, Pulmonary hypertension in chronic neonatal lung disease, Paediatric Respiratory Reviews, vol.11, issue.3
DOI : 10.1016/j.prrv.2010.05.001

G. Lacour, A. Zamora, S. Bertrand, R. , B. Perret et al., Colonisation par Ureaplasma urealyticum et maladie pulmonaire chronique chez les nouveau-nés prématurés de moins de 32 semaines de gestation. Arch Pédiatrie, pp.39-46, 2001.

Y. Aujard, L. Maury, C. Doit, P. Mariani-kurkdjian, O. Baud et al., Ureaplasma urealyticum, Mycoplasma hominis et pathologiesn??onatales : Donn??es personnelles et revue de la litt??rature, Archives de P??diatrie, vol.12, pp.12-20, 2005.
DOI : 10.1016/S0929-693X(05)80004-1

R. Bhat, A. Salas, C. Foster, W. Carlo, and N. Ambalavanan, Prospective analysis of pulmonary hypertension in extremely low birth weight infants. Pediatrics, pp.682-691, 2012.

N. Porta and R. Steinhorn, Pulmonary Vasodilator Therapy in the NICU: Inhaled Nitric Oxide, Sildenafil, and Other Pulmonary Vasodilating Agents, Clinics in Perinatology, vol.39, issue.1, pp.149-64, 2012.
DOI : 10.1016/j.clp.2011.12.006

P. Kumar, C. Fetus, and . Newborn, Use of Inhaled Nitric Oxide in Preterm Infants, PEDIATRICS, vol.133, issue.1, pp.164-70, 2014.
DOI : 10.1542/peds.2013-3444

P. Mourani, D. Ivy, D. Gao, and S. Abman, Pulmonary Vascular Effects of Inhaled Nitric Oxide and Oxygen Tension in Bronchopulmonary Dysplasia, American Journal of Respiratory and Critical Care Medicine, vol.170, issue.9, pp.1006-1019, 2004.
DOI : 10.1164/rccm.200310-1483OC

J. Kinsella, G. Cutter, W. Walsh, D. Gerstmann, C. Bose et al., Early Inhaled Nitric Oxide Therapy in Premature Newborns with Respiratory Failure, New England Journal of Medicine, vol.355, issue.4, pp.354-64, 2006.
DOI : 10.1056/NEJMoa060442

N. Ambalavanan and P. Mourani, Pulmonary hypertension in bronchopulmonary dysplasia, Birth Defects Research Part A: Clinical and Molecular Teratology, vol.40, issue.1, pp.240-246, 2014.
DOI : 10.1002/bdra.23241

M. Nyp, T. Sandritter, N. Poppinga, C. Simon, and W. Truog, Sildenafil citrate, bronchopulmonary dysplasia and disordered pulmonary gas exchange: any benefits?, Journal of Perinatology, vol.8, issue.1, pp.64-73, 2012.
DOI : 10.2459/JCM.0b013e328332e745

I. Schulze-neick, P. Hartenstein, J. Li, B. Stiller, N. Nagdyman et al., Intravenous Sildenafil Is a Potent Pulmonary Vasodilator in Children With Congenital Heart Disease, Circulation, vol.108, issue.90101, pp.167-73, 2003.
DOI : 10.1161/01.cir.0000087384.76615.60

C. Stocker, D. Penny, C. Brizard, A. Cochrane, R. Soto et al., Intravenous sildenafil and inhaled nitric oxide: a randomised trial in infants after cardiac surgery, Intensive Care Medicine, vol.29, issue.11, pp.1996-2003, 2003.
DOI : 10.1007/s00134-003-2016-4

A. Lammers, S. Haworth, and C. Pierce, Intravenous sildenafil as an effective treatment of pulmonary hypertensive crises during acute intestinal malabsorption, Cardiol Young, 2006.

J. Lee, S. Hillier, and C. Knoderer, Use of Sildenafil to Facilitate Weaning From Inhaled Nitric Oxide in Children With Pulmonary Hypertension Following Surgery for Congenital Heart Disease, Journal of Intensive Care Medicine, vol.29, issue.11, pp.329-363, 2008.
DOI : 10.1177/0885066608321389

H. Baquero, A. Soliz, F. Neira, M. Venegas, and A. Sola, Oral Sildenafil in Infants With Persistent Pulmonary Hypertension of the Newborn: A Pilot Randomized Blinded Study, PEDIATRICS, vol.117, issue.4, 2006.
DOI : 10.1542/peds.2005-0523

G. Martínez, E. Ibarra-de-la-rosa, I. , P. Navero, J. et al., Sildenafil in the treatment of pulmonary hypertension]. An Pediatría Barc Spain, pp.110-113, 2003.

A. Fraisse, G. Butrous, M. Taylor, M. Oakes, M. Dilleen et al., Intravenous sildenafil for postoperative pulmonary hypertension in children with congenital heart disease. Intensive Care Med, pp.502-511, 2011.

R. Barst, D. Ivy, G. Gaitan, A. Szatmari, A. Rudzinski et al., A randomized, doubleblind , placebo-controlled, dose-ranging study of oral sildenafil citrate in treatment-naive children with pulmonary arterial hypertension. Circulation, pp.324-358, 2012.

H. Kahveci, O. Yilmaz, U. Avsar, M. Ciftel, O. Kilic et al., Oral sildenafil and inhaled iloprost in the treatment of pulmonary hypertension of the newborn, Pediatric Pulmonology, vol.154, issue.12, 2014.
DOI : 10.1002/ppul.22985

K. Samada, H. Shiraishi, J. Aoyagi, and M. Momoi, Cerebral hemorrhage associated with sildenafil (Revatio) in an infant. Pediatr Cardiol, pp.998-1007, 2009.

S. Nemoto, T. Sasaki, H. Ozawa, T. Katsumata, K. Kishi et al., Oral sildenafil for persistent pulmonary hypertension early after congenital cardiac surgery in children???, European Journal of Cardio-Thoracic Surgery, vol.38, issue.1, pp.71-78, 2010.
DOI : 10.1016/j.ejcts.2010.01.045

A. Carls, J. Winter, Y. Enderle, J. Burhenne, M. Gorenflo et al., Substantially increased sildenafil bioavailability after sublingual administration in children with congenital heart disease: two case reports, Journal of Medical Case Reports, vol.100, issue.Suppl 1, p.171, 2014.
DOI : 10.1016/j.ijcard.2004.09.002

A. Wardle and R. Tulloh, Evolving Management of Pediatric Pulmonary Arterial Hypertension: Impact of Phosphodiesterase Inhibitors, Pediatric Cardiology, vol.48, issue.Suppl 1, pp.213-222, 2013.
DOI : 10.1007/s00246-012-0598-8

T. Kulik, L. Rhein, and M. Mullen, Pulmonary Arterial Hypertension in Infants with Chronic Lung Disease: Will We Ever Understand It?, The Journal of Pediatrics, vol.157, issue.2, pp.186-90, 2010.
DOI : 10.1016/j.jpeds.2010.03.022

R. Steinhorn, J. Kinsella, and S. Abman, Beyond Pulmonary Hypertension: Sildenafil for Chronic Lung Disease of Prematurity, American Journal of Respiratory Cell and Molecular Biology, vol.48, issue.2, p.iii ? v, 2013.
DOI : 10.1165/rcmb.2012-0441ED

K. Tropea and H. Christou, Current Pharmacologic Approaches for Prevention and Treatment of Bronchopulmonary Dysplasia, International Journal of Pediatrics, vol.77, issue.3, p.598606, 2012.
DOI : 10.1164/rccm.201101-0055OC